This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?
Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
El ondansetrón, ampliamente utilizado para controlar las náuseas en pacientes de hemodiálisis, ha sido el centro de una importante discusión por su posible relación con eventos cardíacos, como la muerte súbita.
Un análisis reciente sugiere que, aunque es efectivo, su uso podría estar asociado con riesgos no contemplados previamente en pacientes en hemodiálisis. Revisa el resumen visual realizado por Santhoshi Bavi y únete a la conversación en nuestro próximo #NephJC.
Is the use of Ondensetron safe in patients on hemodialysis? Checkout the VA by NSMC intern Santhoshi Bavi
